- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03232814
Walk on: A Community-based Approach to Increase Physical Activity Among Men Treated for Colorectal Cancer
Walk on: A Community-based Approach to Promote Participation in Physical Activity Among Men Treated for Colorectal Cancer
In Canada, over 102,900 men are diagnosed with cancer each year. Of these, 81,000 are diagnosed with colorectal cancer and an estimated 65% are expected to survive the disease for at least 5 years. Men who have completed treatment for colorectal cancer face many adverse physical, cognitive, psychological, and social effects. The Wellness Beyond Cancer Program at The Ottawa Hospital is a cancer survivorship program that helps people who have completed treatment for cancer, including men diagnosed with colorectal cancer, manage these effects. The Wellness Beyond Cancer Program does this through education and referral to supportive care services and programs offered throughout the city of Ottawa.
Group-based physical activity programs are one of the varied services and programs available to adults diagnosed with cancer in Ottawa. Such programs are offered through the Ottawa Regional Cancer Foundation (http://www.ottawacancer.ca) and Breast Cancer Action Ottawa (http://bcaott.ca). Research on these programs show that group-based physical activity can improve disease and treatment-related effects while promoting overall quality of life amongst women with cancer. However, few of these programs have targeted men, even though their needs and preferences have been shown to be very different from women. While men diagnosed with colorectal cancer might also benefit from group-based physical activity programs offered in the community, it is not known if such programs would effectively reach them and what the impact would be on their quality of life after cancer treatment.
It is believed that a men's group-based walking program could be an effective way to reach men and promote quality of life after cancer treatment. Therefore, a sustainable 8-week group-based walking program was developed. This project will seek to explore the feasibility and potential benefits of the program among men who have completed treatment for colorectal cancer and who are referred to the program from staff at the Wellness Beyond Cancer Program in a prospective single-arm trial.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Ontario
-
Ottawa, Ontario, Canada, K1N 6N5
- University of Ottawa
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Men 18 years of age or older;
- Have completed treatment for colorectal cancer <1 year;
- Willing to provide informed consent to participate in this study and willing to follow the study protocol;
- Have the ability to walk without the use of an assistive device (including a cane) or the help of another person;
- Able to read and understand English;
- Medically cleared to participate in the walking program as determined by their referring Wellness Beyond Cancer Program healthcare provider.
Exclusion Criteria:
- Congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, uncontrolled angina, uncontrolled arrhythmia, myocardial infarction, major heart surgery, stroke, or pulmonary embolus;
- Uncontrolled hypertension (systolic blood pressure>200 mm Hg and/or diastolic blood pressure >110 mm Hg);
- The use of supplemental oxygen;
- Severe arthritis (i.e., osteoarthritis or rheumatoid arthritis);
- History of chest pain or severe shortness of breath either at rest or when engaging in physical activity;
- Hip fracture, hip or knee replacement in the past 6 months;
- Currently enrolled in another study involving a physical activity intervention.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Group-based walking
Participants will engage in one supervised outdoor group-based walking session per week for the 8 week program.
|
The walking prescription will be progressive in nature.
The program will begin with participants walking for approximately 20 minutes in weeks 1-3.
This will gradually increase to approximately 30 minutes in weeks 4-6.
Finally, this will increase to 45-60 minutes in weeks 7-8.
The program will promote walking at a moderate intensity as assessed by Borg's Rating of Perceived Exertion scale.
Each session will be preceded by a brief warm-up and followed by a brief cool-down period.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Recruitment rates
Tidsramme: Through study completion, an average of 8 weeks
|
The number of men who enrol in the study out of the number who are referred.
|
Through study completion, an average of 8 weeks
|
|
Retention rates
Tidsramme: Through study completion, an average of 8 weeks
|
The number of men who complete the intervention and all scheduled assessments.
|
Through study completion, an average of 8 weeks
|
|
Adherence rates
Tidsramme: Through study completion, an average of 8 weeks
|
The number of walking sessions men engage in out of the total recommended as part of the intervention.
|
Through study completion, an average of 8 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Physical Activity Behaviour: Leisure Time Exercise Questionnaire (Godin & Shephard, 1985)
Tidsramme: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported physical activity (over the past 7 days) from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Quality of Life: Functional Assessment of Cancer Therapy (FACT)-Colorectal (Ward et al., 1999; Yost et al. 2005)
Tidsramme: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported quality of life from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Cognitive Functioning: FACT-Cognitive Function (Wagner et al., 2004)
Tidsramme: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported cognitive functioning from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Affect: Positive and Negative Affect Schedule (Watson et al., 1988)
Tidsramme: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported affect from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Depression: Center for Epidemiologic Studies Depression Scale 10-item Revised (Eaton et al., 2004; Radloff, 1977)
Tidsramme: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported depressive symptoms from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Social Support: Relatedness to Others in Physical Activity Scale (Wilson & Bengoechea, 2010)
Tidsramme: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported perceptions of social support from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Physical Self-Perceptions: Physical Self Description Questionnaire Short-Form (Marsh et al., 2010)
Tidsramme: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported physical competence, confidence, and self-esteem from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Stress: Perceived Stress Scale (Cohen et al., 1982)
Tidsramme: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported perceptions of stress from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Fatigue: Functional Assessment of Chronic Illness Therapy-Fatigue Scale (Yellen et al., 1997)
Tidsramme: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported perceptions of fatigue from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Participants' Overall Experiences: Qualitative Interviews
Tidsramme: Post-intervention (week 8)
|
Participants' perspectives on how the intervention contributed to their behavioural, physical, psychological and social functioning, as well as their overall quality of life.
|
Post-intervention (week 8)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Jennifer Brunet, PhD, University of Ottawa
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
- Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
- Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985 Sep;10(3):141-6.
- Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997 Feb;13(2):63-74. doi: 10.1016/s0885-3924(96)00274-6.
- Marsh HW, Martin AJ, Jackson S. Introducing a short version of the physical self description questionnaire: new strategies, short-form evaluative criteria, and applications of factor analyses. J Sport Exerc Psychol. 2010 Aug;32(4):438-82. doi: 10.1123/jsep.32.4.438. Erratum In: J Sport Exerc Psychol. 2010 Dec;32(6):909-11.
- Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res. 1999 May;8(3):181-95. doi: 10.1023/a:1008821826499.
- Yost KJ, Cella D, Chawla A, Holmgren E, Eton DT, Ayanian JZ, West DW. Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches. J Clin Epidemiol. 2005 Dec;58(12):1241-51. doi: 10.1016/j.jclinepi.2005.07.008. Epub 2005 Oct 13.
- Eaton WW, Muntaner C, Smith C, Tien A, Ybarra M. Center for Epidemiologic Studies Depression Scale: Review and revision (CESD and CESD-R), in The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, M.E. Maruish, Editor. 2004, Lawrence Erlbaum: Mahwah, NJ. p. 363-377.
- Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1977. 1: p. 385-401.
- Wagner L, Lai J-S, Cella D, Sweet J, Forrestal S. Chemotherapy-related cognitive deficits: development of the FACT-Cog instrument. Ann Behav Med, 2004. 27: p. S10.
- Wilson PM, Bengoechea EG. The relatedness to others in physical activity scale: evidence for structural and criterion validity. Journal of Applied Biobehavioral Research, 2010. 15(2): p. 61-87.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- WBCP:PA/CR
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Tykktarmskreft
-
Stingray TherapeuticsRekrutteringRefractory Metastatic Microsatelite Stabil Colorectal Cancer (MSS-CRC)Forente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)FullførtMetastatisk kolorektalt karsinom | Trinn IV tykktarmskreft AJCC v8 | Stage IVA tykktarmskreft AJCC v8 | Stage IVB tykktarmskreft AJCC v8 | Stage IVC Colorectal Cancer AJCC v8Forente stater
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)FullførtTrinn IV tykktarmskreft AJCC v7 | Stage IVA kolorektal kreft AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Kolorektalt adenokarsinom | RAS Wild TypeForente stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)Har ikke rekruttert ennåMetastatisk kolorektalt karsinom | Stage IVC Colorectal Cancer AJCC v8 | Ikke-opererbart kolorektalt karsinom | Metastatisk appendix karsinom | Metastatisk malign neoplasma i bukhinnen | Stage IV vedlegg Karsinom AJCC v8Forente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)FullførtTrinn IV tykktarmskreft AJCC v7 | Stage IVA kolorektal kreft AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatisk karsinom i leveren | Resektabel masseForente stater
-
Ning JinFullførtMetastatisk kolorektalt karsinom | Trinn IV tykktarmskreft AJCC v8 | Stage IVA tykktarmskreft AJCC v8 | Stage IVB tykktarmskreft AJCC v8 | Stage IVC Colorectal Cancer AJCC v8Forente stater
-
M.D. Anderson Cancer CenterRekrutteringMetastatisk malign neoplasma i leveren | Metastatisk kolorektalt karsinom | Trinn IV tykktarmskreft AJCC v8 | Stage IVA tykktarmskreft AJCC v8 | Stage IVB tykktarmskreft AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Resektabelt kolorektalt karsinomForente stater
-
University of California, San FranciscoMerck Sharp & Dohme LLCFullførtTrinn IV tykktarmskreft AJCC v7 | Stage IVA kolorektal kreft AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Mikrosatellitt stabil | Trinn III tykktarmskreft AJCC v7 | Trinn IIIB tykktarmskreft AJCC v7 | Stage IIIC tykktarmskreft AJCC v7 | Mismatch Repair Protein dyktigForente stater
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)FullførtTrinn IV tykktarmskreft AJCC v7 | Stage IVA kolorektal kreft AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Tilbakevendende kolorektalt karsinom | Metastatisk karsinom i leverenForente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RekrutteringStage IV Bukspyttkjertelkreft AJCC v6 og v7 | Metastatisk kolorektal adenokarsinom | Trinn IV tykktarmskreft AJCC v7 | Stage IVA kolorektal kreft AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatisk bukspyttkjertelduktalt adenokarsinomForente stater
Kliniske studier på Group-based walking
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Fullført
-
University of ValenciaFullførtKoronavirusinfeksjon | LuftveissykdomSpania
-
Pennington Biomedical Research CenterAvsluttetKognitiv sviktForente stater
-
National Yang Ming UniversityTilbaketrukket
-
Suleyman Demirel UniversityHar ikke rekruttert ennåPedagogiske intervensjoner | Palpasjonsevner | Fysisk terapiopplæring | Helseprofesjonsutdanning
-
Istanbul Medeniyet UniversityHar ikke rekruttert ennåDepresjon | Understreke | Angst | Velvære, psykologisk
-
Riphah International UniversityFullførtCerebral paresePakistan
-
State University of New York at BuffaloFullført
-
Craig HospitalHar ikke rekruttert ennå
-
Clemson UniversityFullførtMangel på fysisk aktivitetForente stater